Thrivable Insights
Are We Measuring GLP-1 Success Too Narrowly?
GLP-1 receptor agonists have transformed the treatment landscape for obesity and diabetes, and for...
2 minute read
If GLP-1 Therapies Are Approved for Type 1 Diabetes, Patient Support Will Matter as Much as the Medication
For more than 100 years, nearly every major breakthrough in type 1 diabetes has focused on one...
4 minute read
[Webinar] The Great GLP-1 Shift: How Patient Mindset Is Reshaping Diabetes Care, Support, and Strategy
Recorded on June 24, 2026. With GLP-1 adoption rising from just 3% in 2021 to 23% in 2025,...
1 minute read
Patients Who Persist: What Diabetes Patient Stories Reveal About the GLP-1 Treatment Journey
Despite the widespread popularity of GLP-1 medications in the U.S., nearly three in four diabetes...
1 minute read
Beyond the Starts: The Hidden Moments Driving 2.1 Million GLP-1 Patient Adherence Opportunity
Explore the hidden moments that shape patient expectations, motivation, and long-term adherence in...How Target Patients Ranked the 2026 Super Bowl Commercials for GLP-1 Drugs
The 2026 Super Bowl wasn’t just a showdown on the field, it was a battle of brands off of it. As...
5 minute read
How Geography and Urbanicity Are Shaping the GLP-1 Landscape
Learn why, despite consistent provider conversations across regions, our data suggests differences...Case Study: Accelerating Nationwide Clinical Trial Recruitment for a Top 10 US Research Institution
Project Overview A top 10 US research institution was conducting a nationwide clinical trial in...
2 minute read
From Gut Feel to Clarity: 3 Steps to Smarter Brand Decisions
Every commercial and brand leader has experienced it: the monthly performance review where...
3 minute read